SNNU.F Stock Overview
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Smith & Nephew plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£12.39 |
52 Week High | UK£16.74 |
52 Week Low | UK£10.80 |
Beta | 0.51 |
1 Month Change | -2.52% |
3 Month Change | -9.56% |
1 Year Change | -19.86% |
3 Year Change | -39.78% |
5 Year Change | -36.79% |
Change since IPO | 108.24% |
Recent News & Updates
Recent updates
Shareholder Returns
SNNU.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 2.7% | -2.9% | -3.2% |
1Y | -19.9% | -3.7% | 19.3% |
Return vs Industry: SNNU.F underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: SNNU.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
SNNU.F volatility | |
---|---|
SNNU.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SNNU.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SNNU.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1856 | 18,452 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
SNNU.F fundamental statistics | |
---|---|
Market cap | US$10.67b |
Earnings (TTM) | US$263.00m |
Revenue (TTM) | US$5.55b |
40.2x
P/E Ratio1.9x
P/S RatioIs SNNU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SNNU.F income statement (TTM) | |
---|---|
Revenue | US$5.55b |
Cost of Revenue | US$1.66b |
Gross Profit | US$3.89b |
Other Expenses | US$3.63b |
Earnings | US$263.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.30 |
Gross Margin | 70.14% |
Net Profit Margin | 4.74% |
Debt/Equity Ratio | 55.3% |
How did SNNU.F perform over the long term?
See historical performance and comparison